Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2010.0115


Laparoscopic D2 gastrectomy: A new horizon even in the West

Prof. Ernst Hanisch, M.D.

Affiliation: Prof. Ernst Hanisch, Chefarzt und Ärztlicher Direktor, Klinik für Allgemein- Viszeral- und Endokrine Chirurgie, Asklepios Klinik Langen, Akademisches Lehrkrankenhaus der JWG-Universität Frankfurt, Röntgenstr 20, 63225 Langen .

Tel 06103/912 61200; FAX 06103/9121814,



Since there is no abstract available we provide the first paragraph .

Open gastrectomy with extended (D2) lymphadenectomy for the treatment of resectable gastric cancer has become the de facto standard of care in Japan and Korea . Excellent outcomes for advanced stages of this disease have reported recently from a high-quality, multicenter, phase III, randomized, controlled trial at 24 hospitals in Japan [1]. Sasako et al. reported a 5-year survival rate of 70% with extended lymphadenectomy for Japanese stages II and III disease without adjuvant treatment [1]. Yet, these results represent a dream for the real western world [2]. Even in specialized institutions in the west, 5-year survival rate for these advanced stages is reported to be less than 40%, and notably these data are derived from nonrandomized studies [3].



You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €33 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 30 January 2010